feed,title,long_url,short_url
Benzinga,This Analyst Believes Biogen's Lecanemab Data Not 'Slam Dunk' For Complete CMS Approval,https://benzinga.com/analyst-ratings/analyst-color/22/09/29056677/this-analyst-believes-biogens-lecanemab-data-not-slam-dunk-for-complete-cms-approva,https://bit.ly/3RljAo9
